AGC Partners is pleased to announce that its client, Greenphire, Inc., a leading provider of financial workflow management and payment solutions for clinical trials, has reached an agreement to be acquired by Thoma Bravo. The deal, which is subject to customary regulatory approvals, is expected to close in the second quarter of this year. Greenphire's end-to-end solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and contract research organizations (CROs) to sites and patients in more than 70 countries. The acquisition will enable Greenphire to build on the Company's growth and success. With a team led by Hugh Hoffman and Ben Howe, AGC Partners acted as financial advisor to Greenphire. To view the announcement click here.
"We have greatly appreciated AGC Partners' continuous commitment to Greenphire over the past several years and their work during our process. Hugh Hoffman's expertise and knowledge, not only in Clinical Trials but across the broader ecosystem of Life Sciences Technology and HCIT, was highly valuable in the positioning of Greenphire for our successful outcome. Coupled with the great support of Ben Howe and the 24x7 execution of the broader AGC Team, AGC Partners is highly regarded by The Riverside Company and Greenphire."